VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
ACOG
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
ACOGAlpha Cognition Inc. Common Stock
$6.81$106M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksACOGBalance Sheet

Alpha Cognition Inc. Common Stock (ACOG) Balance Sheet

6Y historyFree accessUpdated daily

The company maintains a liquid position with $54.2M in cash, though this is offset by a substantial accumulated deficit in retained earnings totaling $103.6M.

ACOG Balance Sheet

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20
Total Current Assets68.56M79.01M50.25M1.92M2.33M12.17M7.7M
Cash & Short-Term Investments-------
Cash Only-------
Short-Term Investments-------
Accounts Receivable-------
Days Sales Outstanding-------
Inventory-------
Days Inventory Outstanding-------
Other Current Assets4.69M3.55M17.87K366.32K000
Total Non-Current Assets691.51K719.96K485.76K533.73K618.21K709.76K735.97K
Property, Plant & Equipment0328.54K27.08K1.72K3.82K13K6.84K
Fixed Asset Turnover107.96x31.11x-----
Goodwill0391.42K00000
Intangible Assets386.04K0412.97K532.01K614.39K696.76K729.14K
Long-Term Investments0000000
Other Non-Current Assets-------
Total Assets69.25M79.73M50.74M2.45M2.95M12.88M8.44M
Asset Turnover0.18x0.13x-----
Asset Growth %2987.75%57.14%1969.06%-16.9%-77.09%52.68%-
Total Current Liabilities5.43M9.13M3.35M2.62M4.06M1.8M3.58M
Accounts Payable08.98M872.68K02.02M454.99K27.54K
Days Payables Outstanding-------
Short-Term Debt00911.46K1.22M1.21M1.08M24K
Deferred Revenue (Current)0------
Other Current Liabilities5.31M0643.06K602.84K550.66K03.34M
Current Ratio12.64x8.65x15.00x0.73x0.58x6.75x2.15x
Quick Ratio12.64x8.65x15.00x0.73x0.58x6.75x2.15x
Cash Conversion Cycle-------
Total Non-Current Liabilities6.37M8.07M5.92M4.54M214.28K2.05M4.84M
Long-Term Debt0000003.19M
Capital Lease Obligations0------
Deferred Tax Liabilities0------
Other Non-Current Liabilities-------
Total Liabilities11.79M17.2M9.27M7.16M4.27M3.85M8.42M
Total Debt00911.46K1.22M1.21M1.08M3.22M
Net Debt-54.25M-66.11M-47.63M-274.2K-872.23K-10.23M-2.71M
Debt / Equity0.00x-0.02x--0.12x200.84x
Debt / EBITDA-0.00x------
Net Debt / EBITDA2.01x------
Interest Coverage---77.79x-202.40x-69.08x-36.01x-6.51x
Total Equity57.46M62.53M41.46M-4.71M-1.32M9.03M16.01K
Equity Growth %3742.16%50.81%979.83%-256.97%-114.62%56306.74%-
Book Value per Share2.623.545.72-1.31-0.494.230.01
Total Shareholders' Equity57.46M62.53M41.46M-4.71M-1.32M9.03M16.01K
Common Stock133.95M133.89M99.13M50.35M40.26M40.01M14.57M
Retained Earnings-103.58M-97.11M-76.29M-63.35M-49.99M-38.03M-18.49M
Treasury Stock0000000
Accumulated OCI-104.3K-104.3K-104.3K8.29M8.41M7.05M3.94M
Minority Interest0000000

Key Metrics

Growth RegimeExpanding
ProfitabilityNegative
Balance SheetStrained
Cash FlowBurning
Top Statement Risk

Commercial execution and liquidity

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Capital Base Expansion Amid Losses

According to recent balance sheet data, Alpha Cognition has grown its total assets to $69.2M as of 2026Q1, yet this expansion is primarily fueled by external financing rather than organic value creation, as evidenced by the persistent accumulation of a $103.6M deficit in retained earnings.

The trajectory of the balance sheet reflects a company in a high-stakes transition phase where asset growth is decoupled from operational profitability. Investors should monitor whether the current asset base can be leveraged to generate sufficient commercial returns before the accumulated deficit further erodes the equity position.

Cash Runway Facing Commercial Pressure

As reported in financial statements, the company maintains a cash position of $54.2M in 2026Q1, which provides a necessary buffer for operations, though the rapid decline from $66.1M in 2025Q4 suggests that the current burn rate may necessitate additional capital infusions within the next year.

While the current ratio of 12.64 appears robust, it is heavily skewed by the cash balance relative to minimal current liabilities, masking the underlying reality of high operational cash outflows. The company's liquidity profile remains highly sensitive to the success of its commercial launch, as any delay in revenue scaling will accelerate the depletion of these reserves.

Equity Quality Diluted by Losses

Based on the company's reported figures, equity has fluctuated significantly, reaching $57.5M in 2026Q1, a trend that underscores the volatility inherent in a clinical-stage entity that has historically relied on equity financing to offset substantial operating losses and negative retained earnings.

The quality of equity is currently constrained by the massive accumulated deficit, which suggests that shareholders are bearing the full brunt of the company's R&D and commercialization costs. Future equity stability will likely depend on the company's ability to demonstrate a path toward positive net income, thereby arresting the ongoing erosion of book value.

Hidden Risks in Asset Composition

Analysis of the balance sheet reveals that the company's asset base is almost entirely composed of cash, with negligible tangible assets or PPE, which may indicate that the firm's true value is tied to intangible intellectual property that is not fully captured on the balance sheet.

The lack of significant PPE suggests an asset-light model that is highly dependent on the successful commercialization of its prodrug technology. Investors should be wary that the headline asset figures provide little protection in a downside scenario, as the company's value is almost exclusively tied to the future market potential of its pipeline.

ACOG — Frequently Asked Questions

Quick answers to the most common questions about buying ACOG stock.

What are the total assets of Alpha Cognition Inc. Common Stock (ACOG)?

As of 2025, Alpha Cognition Inc. Common Stock (ACOG) had total assets of $79.7M including $79.0M in current assets.

How much debt does Alpha Cognition Inc. Common Stock (ACOG) have?

Alpha Cognition Inc. Common Stock (ACOG) carries total debt of $0.0M. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of Alpha Cognition Inc. Common Stock?

Alpha Cognition Inc. Common Stock (ACOG) has total shareholders' equity (book value) of $62.5M ($3.54 book value per share). Book value represents the net worth of the company belonging to common stock holders.

What is Alpha Cognition Inc. Common Stock's current ratio and liquidity?

Alpha Cognition Inc. Common Stock (ACOG) reported a current ratio of 8.65x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.